DV500 (Divalproex Sodium Delayed-Release 500 mg)
Pill with imprint DV500 is Purple, Elliptical/Oval and has been identified as Divalproex Sodium Delayed-Release 500 mg. It is supplied by Genpharm Inc.
Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DV500
Divalproex Sodium Delayed-Release
- Imprint
- DV500
- Strength
- 500 mg
- Color
- Purple
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genpharm Inc.
- National Drug Code (NDC)
More about divalproex sodium
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (461)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: fatty acid derivative anticonvulsants
Patient resources
- Drug Information
- Divalproex sodium (Advanced Reading)
- Divalproex Sprinkle Capsules
- Divalproex Long-Acting Tablets
- Other brands
- Depakote, Depakote ER, Depakote Sprinkles
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.